
JANX vs JBIO
$JANX vs $JBIO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
JANX vs JBIO: the quick read
- ·JBIO is the larger company by market cap ($1.26B vs $1.21B).
- ·JBIO has been more active on our scanner (41 vs 39 alerts in 30 days).
- ·JBIO has the smaller float (50.2M vs 56.0M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 41 and 39 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 4% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing JANX and JBIO on TheDesperateTrader.
- Is JANX or JBIO the better stock?
- "Better" depends on your goal, and these two are not alike. JBIO is the larger company by market cap ($1.26B vs $1.21B). JBIO has been more active on our scanner (41 vs 39 alerts in 30 days). JBIO has the smaller float (50.2M vs 56.0M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between JANX and JBIO?
- The differences that matter: they are similar in size ($1.21B vs $1.26B); they trade at very different share prices ($20.50 vs $19.90); JANX sits at 36% of its 52-week range against 62% for JBIO; our scanner flagged JANX 39 times in the last 30 days against 41 for JBIO. Everything above is measured from the latest completed session and SEC filings.
- Which of JANX and JBIO is more active right now?
- Right now JANX is at about 0.9x its normal volume and JBIO is at about 0.8x, so JANX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading JANX or JBIO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore JANX and JBIO comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.